Literature DB >> 3263927

Effects of IGF-I, EGF, and FGF on proteoglycans synthesized by fractionated chondrocytes of rat rib growth plate.

A M Makower1, J Wroblewski, A Pawlowski.   

Abstract

The effects of insulin-like growth factor (IGF-I), epidermal growth factor (EGF), fibroblast growth factor (FGF), or 10% newborn calf serum (NCS) on the amount and structure of the proteoglycans synthesized by fractionated chondrocytes from rat growth plate were investigated. Proliferative cells (fraction II) or resting cells (fraction III) synthesized more proteoglycans than hypertrophic cells (fraction I). Addition of IGF-I to the cultures increased proteoglycan synthesis more than addition of EGF or FGF. EGF and FGF induced synthesis of proteoglycans of smaller molecular size with a lower proportion of aggregates. The size of the constituent glycosaminoglycan chains did not differ between control and growth factor-treated cells. The present study demonstrates that proteoglycan structure and synthesis are modified by growth factors to different extents, depending on the maturation stage of the target cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263927     DOI: 10.1016/0014-4827(88)90287-x

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

1.  Insulinlike growth factor gene expression in human fracture callus.

Authors:  J G Andrew; J Hoyland; A J Freemont; D Marsh
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

2.  Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I.

Authors:  P M van der Kraan; E L Vitters; N S Postma; J Verbunt; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

3.  Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo.

Authors:  E B Hunziker; J Wagner; J Zapf
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.